# Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery

> **NCT02189889** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 5 (actual)

## Conditions studied

- Anemia
- Cardiovascular Disease

## Interventions

- **DRUG:** EPO
- **DRUG:** Feraheme

## Key facts

- **NCT ID:** NCT02189889
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04-09
- **Primary completion:** 2019-07-26
- **Final completion:** 2019-07-26
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Initial patients were seen at St Paul Hospital. Enrollment changes occurred with the move to Clements Hospital. We were unable to identify an infusion room at CUH despite an exhaustive search for alternatives and forced to terminate early.
- **Last updated:** 2020-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02189889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02189889, "Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02189889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*